Related Experiment Video
Updated: Dec 30, 2025
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Quantitation of Cell-Derived Microparticles in Blood Products and Its Potential Applications in Transfusion
1Research Division, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract:
Cell-derived microparticles (MPs) are small fragments released from various cells when they are activated or undergo apoptosis. In the field of transfusion medicine, a number of studies have documented increased levels of MPs in blood products, which have been associated with multiple factors, including donor variability, blood component processing, and storage. In addition, transfusions that contain high levels of MPs are linked to posttransfusion complications. Considering the clinical importance of MP levels, transfusion laboratories should routinely screen blood products for them. However, this practice is not yet applied routinely, perhaps in part because of a lack of understanding of how to apply MP data to transfusion medicine. We describe the methods used to quantitate MPs in blood components and discuss the application of these quantitative data in routine transfusion laboratories in order to manage quality, improve the outcomes of transfusions, and minimize their complications.
Insights
Cell-derived microparticles (MPs) in blood products are linked to complications. Routine screening of blood products for MPs is crucial for transfusion medicine to improve quality and patient outcomes.
Area of Science:
- Transfusion Medicine
- Cellular Biology
Background:
- Cell-derived microparticles (MPs) are released from activated or apoptotic cells.
- Elevated MP levels in blood products are associated with donor variability, processing, and storage.
- High MP levels in transfusions correlate with posttransfusion complications.
Purpose of the Study:
- To highlight the clinical significance of MP levels in blood products.
- To advocate for routine screening of blood products for MPs in transfusion laboratories.
- To address the lack of understanding in applying MP data to transfusion medicine.
Main Methods:
- Quantitation of MPs in blood components.
- Discussion of the application of quantitative MP data in transfusion laboratories.
Main Results:
- MP quantitation methods are described.
- Application strategies for MP data in routine transfusion settings are discussed.
Conclusions:
- Routine screening of blood products for MPs is recommended for transfusion laboratories.
- Implementing MP data management can enhance transfusion quality and minimize complications.
- Further understanding and application of MP data are vital for advancing transfusion medicine.
